Search Results

BPGbio, Inc., a leading AI-powered biopharma that focuses on oncology, neurology and rare diseases, today announced that it has signed a collaborative agreement with Grupo Terralpe, Inc., a renowned private investment group based in Mexico City and Boston, Mass.

Procaps Group, S.A., a leading integrated LatAm healthcare and pharmaceutical conglomerate, announced the termination of its previously-reported definitive agreement to acquire Grupo Somar from the sellers under the SPA.

C2N Diagnostics announced it has entered a partnership with Grupo Fleury, one of Brazil’s leading healthcare companies, to bring blood-based tests that aid in early Alzheimer’s diagnosis to patient care in Brazil.

Grupo Biotoscana announces to its shareholders and the market in general that has hired Ivan French as Executive VP of Research and Development.

Grupo Biotoscana, a leading biopharmaceutical company in Latin America, today announced a realignment of its management structure to better suit the company´ strategy.

Procaps Group, a leading integrated LatAm healthcare and pharmaceutical conglomerate, announced it has entered into a definitive agreement to acquire Grupo Somar from Advent International, one of the world’s largest private equity investors.

SANUWAVE Health, Inc., a leading provider of next-generation wound care products and its JV partner Diversa S.A. have announced a new distribution agreement with Grupo Suprimed to market and sell the dermaPACE® System in the private healthcare market in Brazil.

LIXTE Biotechnology Holdings, Inc. (Nasdaq: LIXT) (“LIXTE”) announced that the Spanish Sarcoma Research Group (Grupo Español de Investigación en Sarcomas, or GEIS) completed its first site initiation visit in preparation for the advanced soft tissue sarcoma (ASTS) clinical trial at Fundación Jiménez Díaz University Hospital (Madrid).